2,5,7,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-9-nicotinoyloxyjatropha-6(17),11E-diene
Modify Date: 2024-02-24 12:51:02
2,5,7,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-9-nicotinoyloxyjatropha-6(17),11E-diene structure
|
Common Name | 2,5,7,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-9-nicotinoyloxyjatropha-6(17),11E-diene | ||
|---|---|---|---|---|
| CAS Number | 210108-89-7 | Molecular Weight | 779.826 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 797.3±60.0 °C at 760 mmHg | |
| Molecular Formula | C41H49NO14 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 436.0±32.9 °C | |
Use of 2,5,7,14-Tetraacetoxy-3-benzoyloxy-8,15-dihydroxy-9-nicotinoyloxyjatropha-6(17),11E-dieneJatrophane 5 is a natural product of Jatropha carcas L. Jatrophane 5 has powerful inhibition of P-gp, higher than R(+)-verapamil (HY-14275) and Tariquidar (HY-10550) in colorectal multi-drug resistant cells (DLD1-TxR)[1]. |
| Name | (Z)-3-(benzoyloxy)-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-8-(nicotinoyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-1H-cyclopenta[12]annulene-2,4,6,13-tetrayl tetraacetate |
|---|---|
| Synonym | More Synonyms |
| Description | Jatrophane 5 is a natural product of Jatropha carcas L. Jatrophane 5 has powerful inhibition of P-gp, higher than R(+)-verapamil (HY-14275) and Tariquidar (HY-10550) in colorectal multi-drug resistant cells (DLD1-TxR)[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 797.3±60.0 °C at 760 mmHg |
| Molecular Formula | C41H49NO14 |
| Molecular Weight | 779.826 |
| Flash Point | 436.0±32.9 °C |
| Exact Mass | 779.315308 |
| PSA | 211.15000 |
| LogP | 5.46 |
| Vapour Pressure | 0.0±2.9 mmHg at 25°C |
| Index of Refraction | 1.578 |
| Hazard Codes | Xi |
|---|
| (2R,3R,3aS,4R,6R,7S,8S,10Z,12S,13S,13aR)-2,4,6,13-Tetraacetoxy-3-(benzoyloxy)-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-1H-cyclopenta[12]annulen-8-yl nicotinate |
| 3-Pyridinecarboxylic acid, (2R,3R,3aS,4R,6R,7S,8S,10Z,12S,13S,13aR)-2,4,6,13-tetrakis(acetyloxy)-3-(benzoyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-1H-cyclopentacyclododecen-8-yl ester |
| (2R,3R,3aS,4R,6S,7S,8S,10E,12R,13R,13aR)-2,4,6,13-Tetraacetoxy-3-(benzoyloxy)-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-1H-cyclopenta[12]annulen-8-yl nicotinate |
| 3-Pyridinecarboxylic acid, (2R,3R,3aS,4R,6S,7S,8S,10E,12R,13R,13aR)-2,4,6,13-tetrakis(acetyloxy)-3-(benzoyloxy)-2,3,3a,4,5,6,7,8,9,12,13,13a-dodecahydro-7,13a-dihydroxy-2,9,9,12-tetramethyl-5-methylene-1H-cyclopentacyclododecen-8-yl ester |